Search Results - "Mouhieddine, Tarek H."
-
1
A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward
Published in Journal of hematology and oncology (14-07-2020)“…The COVID-19 pandemic, caused by SARS-CoV-2 virus, has resulted in over 100,000 deaths in the USA. Our institution has treated over 2000 COVID-19 patients…”
Get full text
Journal Article -
2
Single cell characterization of myeloma and its precursor conditions reveals transcriptional signatures of early tumorigenesis
Published in Nature communications (17-11-2022)“…Multiple myeloma is a plasma cell malignancy almost always preceded by precursor conditions, but low tumor burden of these early stages has hindered the study…”
Get full text
Journal Article -
3
Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression
Published in The Journal of clinical investigation (01-06-2018)“…Despite significant advances in the treatment of multiple myeloma (MM), most patients succumb to disease progression. One of the major immunosuppressive…”
Get full text
Journal Article -
4
The Akt/mTOR pathway in cancer stem/progenitor cells is a potential therapeutic target for glioblastoma and neuroblastoma
Published in Oncotarget (11-09-2018)“…Nervous system tumors represent some of the highly aggressive cancers in both children and adults, particularly neuroblastoma and glioblastoma. Many studies…”
Get full text
Journal Article -
5
Differences in Nanoparticle Uptake in Transplanted and Autochthonous Models of Pancreatic Cancer
Published in Nano letters (11-04-2018)“…Human pancreatic ductal adenocarcinoma (PDAC) contains a distinctively dense stroma that limits the accessibility of anticancer drugs, contributing to its poor…”
Get full text
Journal Article -
6
MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer
Published in Oncotarget (01-01-2015)“…Aberrant activation of Ras and WNT signaling are key events that have been shown to be up-regulated in prostate cancer that has metastasized to the bone…”
Get full text
Journal Article -
7
Hemophagocytic relapsed intramedullary plasmacytoma
Published in International journal of hematology (01-06-2020)“…We report a case of a relapsed hemophagocytic intramedullary plasmacytoma, previously non-phagocytic, in conjunction with development of a new clone with…”
Get full text
Journal Article -
8
Berberis libanotica Ehrenb extract shows anti-neoplastic effects on prostate cancer stem/progenitor cells
Published in PloS one (07-11-2014)“…Cancer stem cells (CSCs), including those of advanced prostate cancer, are a suggested reason for tumor resistance toward conventional tumor therapy…”
Get full text
Journal Article -
9
Metformin and Ara-a Effectively Suppress Brain Cancer by Targeting Cancer Stem/Progenitor Cells
Published in Frontiers in neuroscience (23-11-2015)“…Gliomas and neuroblastomas pose a great health burden worldwide with a poor and moderate prognosis, respectively. Many studies have tried to find effective…”
Get full text
Journal Article -
10
The Effect of Chronic Methamphetamine Exposure on the Hippocampal and Olfactory Bulb Neuroproteomes of Rats
Published in PloS one (15-04-2016)“…Nowadays, drug abuse and addiction are serious public health problems in the USA. Methamphetamine (METH) is one of the most abused drugs and is known to cause…”
Get full text
Journal Article -
11
Assessing the Lebanese population for their knowledge, attitudes and practices of antibiotic usage
Published in Journal of infection and public health (01-01-2015)“…Summary Antibiotic-resistant bacteria has become a global phenomenon, mainly due to the inappropriate use of antibiotics. There are no studies in Lebanon to…”
Get full text
Journal Article -
12
How to Identify and Manage High-Risk Smoldering Multiple Myeloma
Published in Current oncology reports (23-08-2024)“…It elucidates advancements in identifying and managing high-risk smoldering multiple myeloma (SMM), moving from observation strategies to intervention…”
Get full text
Journal Article -
13
Characterization of the Kallikrein-Kinin System Post Chemical Neuronal Injury: An In Vitro Biochemical and Neuroproteomics Assessment
Published in PloS one (05-06-2015)“…Traumatic Brain Injury (TBI) is the result of a mechanical impact on the brain provoking mild, moderate or severe symptoms. It is acknowledged that TBI leads…”
Get full text
Journal Article -
14
Monoclonal gammopathy of undetermined significance
Published in Blood (06-06-2019)“…Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant plasma cell dyscrasia that consistently precedes multiple myeloma (MM) with a 1%…”
Get full text
Journal Article -
15
Correction: Characterization of the Kallikrein-Kinin System Post Chemical Neuronal Injury: An In Vitro Biochemical and Neuroproteomics Assessment
Published in PloS one (19-08-2015)Get full text
Journal Article -
16
Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma
Published in Cancer cell (09-08-2021)Get full text
Journal Article -
17
Single-cell multi-omics of human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation
Published in Nature genetics (01-10-2022)“…Somatic mutations in cancer genes have been detected in clonal expansions across healthy human tissue, including in clonal hematopoiesis. However, because…”
Get full text
Journal Article -
18
Revisiting the role of alkylating agents in multiple myeloma: Up-to-date evidence and future perspectives
Published in Critical reviews in oncology/hematology (01-07-2023)“…From the 1960s to the early 2000s, alkylating agents (e.g., melphalan, cyclophosphamide, and bendamustine) remained a key component of standard therapy for…”
Get full text
Journal Article -
19
Outcomes with panobinostat in heavily pretreated multiple myeloma patients
Published in Seminars in oncology (01-02-2023)“…Panobinostat is an oral pan histone-deacetylase inhibitor used in the treatment of relapsed and refractory multiple myeloma. Previously published studies of…”
Get full text
Journal Article -
20
Advancements in Nanomedicine for Multiple Myeloma
Published in Trends in molecular medicine (01-06-2018)“…In the past decades, considerable progress has been made in our understanding and treatment of multiple myeloma. Several challenges remain including our…”
Get full text
Journal Article